Viruses 2016, 8(8), 212; doi:10.3390/v8080212
Hepatitis E Pathogenesis
Sébastien Lhomme 1, Olivier Marion 1,2, Florence Abravanel 1, Sabine Chapuy-Regaud 1, Nassim Kamar 2
and Jacques Izopet 1,*
and Jacques Izopet 1,*
1
INSERM, UMR1043, Department of Virology, CHU Purpan, Université Paul Sabatier, 31000 Toulouse, France
2
INSERM, UMR1043, Department of Nephrology, Dialysis and Organ Transplantation, CHU Rangueil, Université Paul Sabatier, 31000 Toulouse, France
*
Author to whom correspondence should be addressed.
Academic Editor: Eric O. Freed
Received: 30 June 2016 / Revised: 22 July 2016 / Accepted: 27 July 2016 / Published: 5 August 2016
(This article belongs to the Special Issue Recent Progress in Hepatitis E Virus Research)
Abstract
Although most hepatitis E virus (HEV) infections are asymptomatic, some can be severe, causing fulminant hepatitis and extra-hepatic manifestations, including neurological and kidney injuries. Chronic HEV infections may also occur in immunocompromised patients. This review describes how our understanding of the pathogenesis of HEV infection has progressed in recent years. View Full-TextKeywords:
hepatitis E virus; pathogenesis; extra-hepatic manifestation; fulminant hepatitis; chronic infection
▼
Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Lhomme, S.; Marion, O.; Abravanel, F.; Chapuy-Regaud, S.; Kamar, N.; Izopet, J. Hepatitis E Pathogenesis. Viruses 2016, 8, 212.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
